Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

ATXIATXI
15 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in Avenue Therapeutics, Inc.

NORTHERN TRUST CORP previously held 0 shares of ATXI (Avenue Therapeutics, Inc.), worth $0 as of 2022-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$69,000

Total Shares Change

-14,568

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q3
Latest
Exited
0
-100.0%
$00.0%$543.75
0
2022-Q2
Unchanged
13,767
0.0%
$4,0000.0%$363.94
0
2022-Q1
Unchanged
13,767
0.0%
$7,0000.0%$578.02
0
2021-Q4
Unchanged
13,767
0.0%
$13,0000.0%$991.13
0
2021-Q3
Unchanged
13,767
0.0%
$21,0000.0%$1,665.00
0
2021-Q2
Decreased
13,767
-82.1%
$35,0000.0%$2,823.75
0
2021-Q1
Decreased
77,049
-6.8%
$467,0000.0%$6,468.75
0
2020-Q4
Increased
82,691
+2.1%
$492,0000.0%$6,525.00
25
2020-Q3
Increased
80,965
+161.3%
$877,0000.0%$12,262.50
40
2020-Q2
Increased
30,989
+112.7%
$334,0000.0%$12,465.00
38
2020-Q1
Unchanged
14,568
0.0%
$130,0000.0%$9,461.25
0
2019-Q4
Unchanged
14,568
0.0%
$140,0000.0%$10,552.50
0
2019-Q3
Unchanged
14,568
0.0%
$87,0000.0%$6,547.50
0
2019-Q2
Unchanged
14,568
0.0%
$92,0000.0%$7,087.50
0
2019-Q1
New
14,568
-
$69,0000.0%$5,343.75
32

Other major holders of ATXI: RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used